Invention Grant
- Patent Title: Antibodies against tissue factor pathway inhibitor
- Patent Title (中): 抗组织因子途径抑制剂的抗体
-
Application No.: US13721755Application Date: 2012-12-20
-
Publication No.: US09574011B2Publication Date: 2017-02-21
- Inventor: Ida Hilden , Berit Olsen Krogh , Jes Thorn Clausen , Ole Hvilsted Olsen , Jens Breinholt , Brian Lauritzen , Brit Binow Soerensen
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Jianjie Hu
- Priority: EP08172520 20081222
- Main IPC: C07K16/38
- IPC: C07K16/38 ; A61K39/00
Abstract:
The invention relates to antibodies that specifically bind to tissue factor pathway inhibitor (TFPI) and that reduce the clotting time of blood. Such antibodies have utility in the treatment of subjects with a coagulopathy.
Public/Granted literature
- US20130251721A1 Antibodies Against Tissue Factor Pathway Inhibitor Public/Granted day:2013-09-26
Information query
